Stay updated on Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Updated the Chile site’s location labeling (Araucania/Temuco) by replacing Spanish “Región de la Araucanía” wording with “Araucania,” and updated the page’s revision footer from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T05:46:55.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:13:05.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T04:44:00.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T00:24:54.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous funding-status notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T12:35:19.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    A government funding lapse notice with NIH Clinical Center status and OPM updates appears at the top of the page, and the page revision is now v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T06:48:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.